The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

被引：0
|
作者：
Tea Rosic
Raveena Kapoor
Balpreet Panesar
Leen Naji
Darren B. Chai
Nitika Sanger
David C. Marsh
Andrew Worster
Lehana Thabane
Zainab Samaan
机构：
[1] McMaster University,Department of Psychiatry and Behavioural Neurosciences
[2] McMaster University,Department of Health Research Methods, Evidence, and Impact
[3] McMaster University,Bachelor of Health Sciences
[4] McMaster University,Neurosciences Graduate Program
[5] McMaster University,Department of Family Medicine
[6] McMaster University,Michael G. DeGroote School of Medicine
[7] McMaster University,Medical Sciences Graduate Program
[8] Northern Ontario School of Medicine,Department of Medicine
[9] Canadian Addiction Treatment Centres,Biostatistics Unit
[10] ICES North,Departments of Pediatrics/Anesthesia
[11] Health Sciences North Research Institute,undefined
[12] McMaster University,undefined
[13] Research Institute at St Joseph’s Healthcare,undefined
[14] McMaster University,undefined
来源：
Harm Reduction Journal | / 18卷
关键词：
Marijuana; Cannabis; Opioid; Polysubstance use; Harm reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
    Rosic, Tea
    Kapoor, Raveena
    Panesar, Balpreet
    Naji, Leen
    Chai, Darren B.
    Sanger, Nitika
    Marsh, David C.
    Worster, Andrew
    Thabane, Lehana
    Samaan, Zainab
    HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [2] The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
    Shams, Ieta
    Sanger, Nitika
    Bhatt, Meha
    Rosic, Tea
    Luo, Candice
    Shahid, Hamnah
    Mouravska, Natalia
    Tam, Sabrina Lue
    Hillmer, Alannah
    Chawar, Caroul
    D'Elia, Alessia
    Hudson, Jacqueline
    Marsh, David
    Thabane, Lehana
    Samaan, Zainab
    BJPSYCH OPEN, 2019, 5 (06):
  • [3] Pharmacological treatment of opioid use disorder in pregnancy
    Rodriguez, Christina E.
    Klie, Kaylin A.
    SEMINARS IN PERINATOLOGY, 2019, 43 (03) : 141 - 148
  • [4] Mu-opioid antagonism in the treatment of cannabis use disorder
    Kebir, Oussama
    Laqueille, Xavier
    Mouaffak, Faycal
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2020, 45 (02): : 143 - 144
  • [5] Prevalence of Cannabis Use and Cannabis Route of Administration among Massachusetts Adults in Buprenorphine Treatment for Opioid Use Disorder
    Streck, Joanna M.
    Regan, Susan
    Bearnot, Benjamin
    Gupta, Priya S.
    Kalkhoran, Sara
    Kalagher, Kelly M.
    Wakeman, Sarah
    Rigotti, Nancy A.
    SUBSTANCE USE & MISUSE, 2022, 57 (07) : 1104 - 1110
  • [6] Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
    Lee, Dustin C.
    Schlienz, Nicolas J.
    Peters, Erica N.
    Dworkin, Robert H.
    Turk, Dennis C.
    Strain, Eric C.
    Vandrey, Ryan
    DRUG AND ALCOHOL DEPENDENCE, 2019, 194 : 500 - 517
  • [7] Cannabis as a Gateway Drug for Opioid Use Disorder
    Williams, Arthur Robin
    JOURNAL OF LAW MEDICINE & ETHICS, 2020, 48 (02): : 268 - 274
  • [8] The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review
    Lake, Stephanie
    St Pierre, Michelle
    CLINICAL PSYCHOLOGY REVIEW, 2020, 82
  • [9] Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only
    De Aquino, Joao P.
    Sofuoglu, Mehmet
    Stefanovics, Elina
    Rosenheck, Robert
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (05): : 527 - 537
  • [10] Opioid maintenance treatment and Cannabis use
    Schneider, Udo
    Schaefer, Ingo
    Hillemacher, Thomas
    Cimander, Konrad F.
    Wedekind, Dirk
    Weirich, Steffen
    Havemann-Reinecke, Ursula
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (10) : 548 - 553
12345